Active Pharmaceutical Ingredient Market Size and Growth Report 2028

Summary

Report Description

Global active pharmaceutical ingredient market is expected to undergo robust growth during the forecast period, 2024-2028. The high adoption rate of generic drugs and increasing demand for speciality medicines are bolstering the growth of the market. The expansion of biopharmaceutical sector along with development of new drugs using active pharmaceutical ingredients are expected to propel the growth of the market. Additionally, rising prevalence of chronic and infectious diseases such as cancer, diabetes, hepatitis A, influenza, among others are surging the market growth. There is a rise in number of people suffering from these diseases, due to which demand for API’s are growing, which, in turn, propel the growth of the market globally. According to the WHO, Cancer is a prominent cause of death worldwide, accounting for approximately 10 million deaths in 2020. The most common cancer was breast cancer with 2.26 million new cases, and lung cancer with 2.21 million new cases.

Moreover, rapid advancements in active pharmaceutical ingredient (API) manufacturing are supporting the market growth. The increasing cases of congenital heart diseases and obesity are also anticipated to drive the market growth through 2028. However, shortening the drug development time and reducing the cost of development are some key issues API manufacturers need to handle, otherwise, it may slow down the growth of the market.

Global active pharmaceutical ingredient market is segmented into type of synthesis, type of manufacturer, route of administration, type of drug, therapeutic application and region. Based on type of manufacturer, the market is segmented into in-house and contract. Among them, the in-house manufacturer segment is expected to dominate the market during the forecast period as innovator companies are increasingly preferring in-house manufacturing to avail economic benefit and prevent technology leakage.

Regionally, North America dominated the global active pharmaceutical ingredient market in 2022 and is further expected to continue its dominance during the forecast period. The presence of adequate manufacturing units and technological advancement in the region are acting as key growth drivers for the market.

Major companies operating in global active pharmaceutical ingredient market include Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Merck & Co., Inc., GlaxoSmithKline Plc, Novartis International AG, F. Hoffmann-La Roche AG, Sanofi S.A., Eli Lilly and Company, and AbbVie Inc. The market players are investing on new product launches through extensive R&D activities. They are also undergoing partnerships, merger and collaborations to increase their share in global market.

Objective of the Study:

· To analyze and forecast the market size of global active pharmaceutical ingredient market.

· To forecast global active pharmaceutical ingredient market based on type of synthesis, type of manufacturer, route of administration, type of drug, therapeutic application, company and regional distribution.

· To identify drivers and challenges for global active pharmaceutical ingredient market.

· To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global active pharmaceutical ingredient market.

· To identify and analyze the profile of leading players operating in the global active pharmaceutical ingredient market.

Download Free Sample Report

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of active pharmaceutical ingredient manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global active pharmaceutical ingredient market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

Active pharmaceutical ingredient companies, vendors, end users, and others.
Government bodies such as regulating authorities and policy makers
Organizations, industry associations, forums and alliances related to active pharmaceutical ingredient
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as active pharmaceutical ingredient companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute	Details
Base Year	2022
Historical Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million and CAGR for 2018-2022 and 2023E-2028F
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	· Type of Synthesis · Type pf Manufacturer · Route of Administration · Type of Drugs · Therapeutic Application · Region
Regional scope	North America; Europe; Asia Pacific; South America; Middle East & Africa
Country scope	United States, Mexico, Canada, China, India, Japan, South Korea, Australia; Germany, France, United Kingdom, Spain, Italy; South Africa, UAE, Saudi Arabia; Brazil, Colombia;
Key companies profiled	Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Merck & Co., Inc., GlaxoSmithKline Plc, Novartis International AG, F. Hoffmann-La Roche AG, Sanofi S.A., Eli Lilly and Company, and AbbVie Inc.
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global active pharmaceutical ingredient market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Active Pharmaceutical Ingredient Market, By Type of Synthesis:

Biotech

Recombinant Proteins
Vaccines
Monoclonal Antibodies

Fermentation
Plant Extracts
Synthetic

Global Active Pharmaceutical Ingredient Market, By Type of Manufacturer:

In-house
Contract

Global Active Pharmaceutical Ingredient Market, By Route of Administration:

Oral
Injectable
Topical

Global Active Pharmaceutical Ingredient Market, By Type of Drug:

Innovative
Generic

Global Active Pharmaceutical Ingredient Market, By Therapeutic Application:

Cardiovascular Disease
Oncology
Neurological Disorders
Orthopedic Disorders
Respiratory
Gastrointestinal Disorders
Urology
Others

Global Active Pharmaceutical Ingredient Market, By Region:

o Asia-Pacific

§ China

§ Japan

§ India

§ South Korea

§ Australia

o Europe & CIS

§ France

§ Germany

§ United Kingdom

§ Italy

§ Spain

o North America

§ United States

§ Mexico

§ Canada

o South America

§ Brazil

§ Colombia

§ Argentina

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global active pharmaceutical ingredient market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

· Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

· Profit margin analysis in case of direct and indirect sales channel.

It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Active Pharmaceutical Ingredient Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Type of Synthesis (Biotech (Recombinant Proteins, Vaccines, Monoclonal Antibodies), Fermentation, Plant Extracts, Synthetic)

5.2.2. By Type of Manufacturer (In-house, Contract)

5.2.3. By Route of Administration (Oral, Injectable, Topical)

5.2.4. By Type of Drug (Innovative, Generic)

5.2.5. By Therapeutic Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, Others)

5.2.6. By Company (2022)

5.2.7. By Region

6. North America Active Pharmaceutical Ingredient Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type of Synthesis

6.2.2. By Type of Manufacturer

6.2.3. By Route of Administration

6.2.4. By Type of Drug

6.2.5. By Therapeutic Application

6.2.6. By Country

6.3. North America: Country Analysis

6.3.1. United States Active Pharmaceutical Ingredient Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Type of Synthesis

6.3.1.2.2. By Type of Manufacturer

6.3.1.2.3. By Route of Administration

6.3.1.2.4. By Type of Drug

6.3.1.2.5. By Therapeutic Application

6.3.2. Mexico Active Pharmaceutical Ingredient Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Type of Synthesis

6.3.2.2.2. By Type of Manufacturer

6.3.2.2.3. By Route of Administration

6.3.2.2.4. By Type of Drug

6.3.2.2.5. By Therapeutic Application

6.3.3. Canada Active Pharmaceutical Ingredient Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Type of Synthesis

6.3.3.2.2. By Type of Manufacturer

6.3.3.2.3. By Route of Administration

6.3.3.2.4. By Type of Drug

6.3.3.2.5. By Therapeutic Application

7. Europe Active Pharmaceutical Ingredient Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Type of Synthesis

7.2.2. By Type of Manufacturer

7.2.3. By Route of Administration

7.2.4. By Type of Drug

7.2.5. By Therapeutic Application

7.2.6. By Country

7.3. Europe: Country Analysis

7.3.1. France Active Pharmaceutical Ingredient Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Type of Synthesis

7.3.1.2.2. By Type of Manufacturer

7.3.1.2.3. By Route of Administration

7.3.1.2.4. By Type of Drug

7.3.1.2.5. By Therapeutic Application

7.3.2. Germany Active Pharmaceutical Ingredient Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Type of Synthesis

7.3.2.2.2. By Type of Manufacturer

7.3.2.2.3. By Route of Administration

7.3.2.2.4. By Type of Drug

7.3.2.2.5. By Therapeutic Application

7.3.3. United Kingdom Active Pharmaceutical Ingredient Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Type of Synthesis

7.3.3.2.2. By Type of Manufacturer

7.3.3.2.3. By Route of Administration

7.3.3.2.4. By Type of Drug

7.3.3.2.5. By Therapeutic Application

7.3.4. Italy Active Pharmaceutical Ingredient Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Type of Synthesis

7.3.4.2.2. By Type of Manufacturer

7.3.4.2.3. By Route of Administration

7.3.4.2.4. By Type of Drug

7.3.4.2.5. By Therapeutic Application

7.3.5. Spain Active Pharmaceutical Ingredient Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Type of Synthesis

7.3.5.2.2. By Type of Manufacturer

7.3.5.2.3. By Route of Administration

7.3.5.2.4. By Type of Drug

7.3.5.2.5. By Therapeutic Application

8. Asia-Pacific Active Pharmaceutical Ingredient Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Type of Synthesis

8.2.2. By Type of Manufacturer

8.2.3. By Route of Administration

8.2.4. By Type of Drug

8.2.5. By Therapeutic Application

8.2.6. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Active Pharmaceutical Ingredient Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Type of Synthesis

8.3.1.2.2. By Type of Manufacturer

8.3.1.2.3. By Route of Administration

8.3.1.2.4. By Type of Drug

8.3.1.2.5. By Therapeutic Application

8.3.2. India Active Pharmaceutical Ingredient Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Type of Synthesis

8.3.2.2.2. By Type of Manufacturer

8.3.2.2.3. By Route of Administration

8.3.2.2.4. By Type of Drug

8.3.2.2.5. By Therapeutic Application

8.3.3. Japan Active Pharmaceutical Ingredient Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Type of Synthesis

8.3.3.2.2. By Type of Manufacturer

8.3.3.2.3. By Route of Administration

8.3.3.2.4. By Type of Drug

8.3.3.2.5. By Therapeutic Application

8.3.4. South Korea Active Pharmaceutical Ingredient Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Type of Synthesis

8.3.4.2.2. By Type of Manufacturer

8.3.4.2.3. By Route of Administration

8.3.4.2.4. By Type of Drug

8.3.4.2.5. By Therapeutic Application

8.3.5. Australia Active Pharmaceutical Ingredient Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Type of Synthesis

8.3.5.2.2. By Type of Manufacturer

8.3.5.2.3. By Route of Administration

8.3.5.2.4. By Type of Drug

8.3.5.2.5. By Therapeutic Application

9. South America Active Pharmaceutical Ingredient Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Type of Synthesis

9.2.2. By Type of Manufacturer

9.2.3. By Route of Administration

9.2.4. By Type of Drug

9.2.5. By Therapeutic Application

9.2.6. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Active Pharmaceutical Ingredient Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Type of Synthesis

9.3.1.2.2. By Type of Manufacturer

9.3.1.2.3. By Route of Administration

9.3.1.2.4. By Type of Drug

9.3.1.2.5. By Therapeutic Application

9.3.2. Argentina Active Pharmaceutical Ingredient Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Type of Synthesis

9.3.2.2.2. By Type of Manufacturer

9.3.2.2.3. By Route of Administration

9.3.2.2.4. By Type of Drug

9.3.2.2.5. By Therapeutic Application

9.3.3. Colombia Active Pharmaceutical Ingredient Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Type of Synthesis

9.3.3.2.2. By Type of Manufacturer

9.3.3.2.3. By Route of Administration

9.3.3.2.4. By Type of Drug

9.3.3.2.5. By Therapeutic Application

10. Middle East and Africa Active Pharmaceutical Ingredient Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Type of Synthesis

10.2.2. By Type of Manufacturer

10.2.3. By Route of Administration

10.2.4. By Type of Drug

10.2.5. By Therapeutic Application

10.2.6. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Active Pharmaceutical Ingredient Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Type of Synthesis

10.3.1.2.2. By Type of Manufacturer

10.3.1.2.3. By Route of Administration

10.3.1.2.4. By Type of Drug

10.3.1.2.5. By Therapeutic Application

10.3.2. Saudi Arabia Active Pharmaceutical Ingredient Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Type of Synthesis

10.3.2.2.2. By Type of Manufacturer

10.3.2.2.3. By Route of Administration

10.3.2.2.4. By Type of Drug

10.3.2.2.5. By Therapeutic Application

10.3.3. UAE Active Pharmaceutical Ingredient Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Type of Synthesis

10.3.3.2.2. By Type of Manufacturer

10.3.3.2.3. By Route of Administration

10.3.3.2.4. By Type of Drug

10.3.3.2.5. By Therapeutic Application

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

13.1. Competition Outlook

13.2. Players Profiled (Leading Companies)

13.2.1. Teva Pharmaceutical Industries Ltd.

13.2.2. Bristol-Myers Squibb Company

13.2.3. Boehringer Ingelheim GmbH

13.2.4. Merck & Co., Inc.

13.2.5. GlaxoSmithKline Plc

13.2.6. Novartis International AG

13.2.7. F. Hoffmann-La Roche AG

13.2.8. Sanofi S.A.

13.2.9. Eli Lilly and Company

13.2.10. AbbVie Inc

Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the factors driving the growth of global active pharmaceutical ingredient market?

Increasing incidences of chronic diseases and surge in development of new drugs are anticipated to drive global active pharmaceutical ingredient market during forecast period.

What are the major segments in global active pharmaceutical ingredient market?

Global active pharmaceutical ingredient market are segmented based on type of synthesis, type of manufacturer, route of administration, type of drug, therapeutic application and region.

Which segment is expected to hold the largest share in global active pharmaceutical ingredient market during forecast period?

Based on type, the in-house manufacturer segment is expected to hold the largest share in global active pharmaceutical ingredient market during forecast period.